The board of directors of Jacobson Pharma Corporation Limited announced that Professor Lam Sing Kwong, Simon ("Professor Lam"), a non-executive director of the Company ("Non-executive Director"), has been re-designated as an independent non-executive director of the Company ("Independent Non-executive Director") with effect from 1 November 2021. Professor Lam will remain as a member of the audit committee of the Board ("Audit Committee") and the chairman of the risk management committee of the Board ("Risk Management Committee"). Professor Lam was appointed as a Non-executive Director of the Company on11 April 2016. On 1 August 2020, Professor Lam was appointed as a member of the Audit Committee and the chairman of Risk Management Committee. Professor Lam is mainly responsible for advising the Board on corporate strategies and governance development. Professor Lam is currently a professor of Management and Strategy at the Faculty of Business and Economics of the University of Hong Kong. Professor Lam obtained a doctorate degree in commerce from the Faculty of Economics and Commerce at the Australian National University in April 1996. Professor Lam has published a number of academic papers and case analyses on the topics of corporate strategy, organisation development and operations management. He has extensive experience in corporate management, strategic development of organizations and corporate finance. Professor Lam is currently an independent non-executive director of Overseas Chinese Town (Asia) Holdings Limited (stock code: 3366), Sinomax Group Limited (stock code: 1418) and Kwan On Holdings Limited (stock code: 1559).